Thyrocare Tech.

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE594H01019
  • NSEID: THYROCARE
  • BSEID: 539871
INR
412.95
5.85 (1.44%)
BSENSE

Feb 09

BSE+NSE Vol: 1.52 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1000893,
    "name": "Thyrocare Tech.",
    "stock_name": "Thyrocare Tech.",
    "full_name": "Thyrocare Technologies Ltd",
    "name_url": "stocks-analysis/thyrocare-tech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "412.95",
    "chg": 5.85,
    "chgp": "1.44%",
    "dir": 1,
    "prev_price": "407.10",
    "mcapval": "6,572.58 Cr",
    "mcap": "Small Cap",
    "scripcode": 539871,
    "symbol": "THYROCARE",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE594H01019",
    "curr_date": "Feb 09",
    "curr_time": "",
    "bse_nse_vol": "1.52 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 09, 2026",
    "traded_date_str": "2026 02 09",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/thyrocare-tech-1000893-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Thyrocare Technologies Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/thyrocare-technologies-ltd-is-rated-buy-3822198",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ThyrocareTechno_mojoScore_3822198.png",
        "date": "2026-02-05 10:10:38",
        "description": "Thyrocare Technologies Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 10 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 February 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, returns, and overall outlook."
      },
      {
        "title": "Thyrocare Technologies Ltd: Valuation Shift Signals Price Attractiveness Amid Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/thyrocare-technologies-ltd-valuation-shift-signals-price-attractiveness-amid-sector-dynamics-3819618",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ThyrocareTechno_valuationdot_3819618.png",
        "date": "2026-02-04 08:02:38",
        "description": "Thyrocare Technologies Ltd has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change reflects evolving market perceptions and impacts the stock’s price attractiveness relative to its historical averages and peer group within the healthcare services sector."
      },
      {
        "title": "Thyrocare Technologies Ltd Falls 5.24%: Volatility and Profit Surge Shape Weekly Moves",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/thyrocare-technologies-ltd-falls-524-volatility-and-profit-surge-shape-weekly-moves-3812840",
        "imagepath": "",
        "date": "2026-01-31 14:00:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jan:</strong> Stock rises 2.43% on solid volume</p>\n                    <p><strong>28 Jan:</strong> Q3 FY26 results reveal stellar profit surge</p>\n                    <p><strong>29 Jan:</strong> Intraday low hit amid sharp price pressure</p>\n                    <p><strong>30 Jan:</strong> Week closes lower at Rs.419.30 (-5.24%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.442.50</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.419.30</div><div class=\"stat-change negative\">-5...."
      },
      {
        "title": "Are Thyrocare Technologies Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-thyrocare-technologies-ltd-latest-results-good-or-bad-3810099",
        "imagepath": "",
        "date": "2026-01-29 19:23:10",
        "description": "Thyrocare Technologies Ltd's latest financial results for Q3 FY26 indicate a notable performance, characterized by significant operational growth and efficiency. The company reported a net profit of ₹47.99 crores, reflecting a substantial year-on-year increase of 79.94%. This growth was supported by a revenue increase of 22.09%, reaching ₹216.53 crores, which also demonstrated robust sequential momentum with a 12.17% rise compared to the previous quarter.\n\nThe operational metrics highlight an operating margin of 32.95%, which is a marked improvement from the prior year's 27.23%, showcasing effective cost management and enhanced asset utilization. Additionally, the profit after tax margin improved significantly to 22.08%, up from 14.90% in the same quarter last year, indicating better earnings quality driven by operational efficiency and a normalized tax rate.\n\nOn a half-yearly basis, Thyrocare's consolidate..."
      },
      {
        "title": "Thyrocare Technologies Ltd Hits Intraday Low Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/thyrocare-technologies-ltd-hits-intraday-low-amid-price-pressure-3809512",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ThyrocareTechno_priceRelatedfactors_3809512.png",
        "date": "2026-01-29 11:01:30",
        "description": "Thyrocare Technologies Ltd experienced a notable decline today, hitting an intraday low of Rs 428, down 6.79% from its previous close, reflecting significant price pressure amid a broadly negative market environment."
      },
      {
        "title": "Thyrocare Technologies Q3 FY26: Profit Surge Masked by Sequential Slowdown",
        "link": "https://www.marketsmojo.com/news/result-analysis/thyrocare-technologies-q3-fy26-stellar-profit-surge-masks-premium-valuation-concerns-3808291",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ThyrocareTechno_quaterlyResult_3808291.png",
        "date": "2026-01-28 19:02:44",
        "description": "Thyrocare Technologies Ltd., India's leading diagnostic services provider, reported consolidated net profit of ₹29.01 crores for Q3 FY26 (October-December 2025), marking a robust year-on-year growth of 51.81% from ₹19.11 crores in Q3 FY25. However, the quarter-on-quarter narrative reveals a different story, with profits declining sharply by 39.55% from ₹47.99 crores in Q2 FY26. The stock, currently trading at ₹403.00 with a market capitalisation of ₹6,659 crores, has delivered exceptional returns of 81.97% over the past year, significantly outperforming the Sensex's 8.49% gain by a commanding 73.48 percentage points."
      },
      {
        "title": "Thyrocare Technologies Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/thyrocare-technologies-ltd-is-rated-buy-3804007",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ThyrocareTechno_mojoScore_3804007.png",
        "date": "2026-01-25 10:10:30",
        "description": "Thyrocare Technologies Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 10 Nov 2025. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 25 January 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Thyrocare Technologies Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/thyrocare-technologies-ltd-sees-mixed-technical-signals-amid-mild-momentum-shift-3799527",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ThyrocareTechno_technicaldot_3799527.png",
        "date": "2026-01-22 08:01:38",
        "description": "Thyrocare Technologies Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late January 2026. Despite a recent day decline of 3.13%, the stock’s broader technical indicators and price action suggest a cautiously optimistic outlook, supported by mixed signals from key momentum oscillators and moving averages. This analysis delves into the evolving technical landscape of Thyrocare, contextualising its performance against sector peers and the broader market."
      },
      {
        "title": "When is the next results date for Thyrocare Technologies Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-thyrocare-technologies-ltd-3799049",
        "imagepath": "",
        "date": "2026-01-21 23:16:28",
        "description": "The next results date for Thyrocare Technologies Ltd is scheduled for 28 January 2026...."
      }
    ],
    "total": 286,
    "sid": "1000893",
    "stock_news_url": "https://www.marketsmojo.com/news/thyrocare-technologies-1000893"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "02-Feb-2026",
      "details": "Please find attached herewith Transcript of Earnings Call held on January 28 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "29-Jan-2026",
      "details": "Please find attached the Newspaper Publications on Unaudited Financial results for the quarter and nine months ended on December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On January 28 2026",
      "datetime": "28-Jan-2026",
      "details": "Outcome of the Board Meeting held on January 28 2026 for the approval of financial results for the quarter and nine months ended December 31 2025 and other matter as detailed in the enclosed letter.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Thyrocare Technologies Ltd has declared <strong>70%</strong> dividend, ex-date: 24 Oct 25",
          "dt": "2025-10-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Thyrocare Technologies Ltd has announced <strong>2:1</strong> bonus issue, ex-date: 28 Nov 25",
          "dt": "2025-11-28",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Thyrocare Technologies Ltd Falls 5.24%: Volatility and Profit Surge Shape Weekly Moves

2026-01-31 14:00:07

Key Events This Week

27 Jan: Stock rises 2.43% on solid volume

28 Jan: Q3 FY26 results reveal stellar profit surge

29 Jan: Intraday low hit amid sharp price pressure

30 Jan: Week closes lower at Rs.419.30 (-5.24%)

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

02-Feb-2026 | Source : BSE

Please find attached herewith Transcript of Earnings Call held on January 28 2026

Announcement under Regulation 30 (LODR)-Newspaper Publication

29-Jan-2026 | Source : BSE

Please find attached the Newspaper Publications on Unaudited Financial results for the quarter and nine months ended on December 31 2025

Board Meeting Outcome for Outcome Of The Board Meeting Held On January 28 2026

28-Jan-2026 | Source : BSE

Outcome of the Board Meeting held on January 28 2026 for the approval of financial results for the quarter and nine months ended December 31 2025 and other matter as detailed in the enclosed letter.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Thyrocare Technologies Ltd has declared 70% dividend, ex-date: 24 Oct 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Thyrocare Technologies Ltd has announced 2:1 bonus issue, ex-date: 28 Nov 25

stock-summary
RIGHTS

No Rights history available